Interestingly, a decreasing trend in receptor activator of nuclear factor kappa B (RANK) and RANK ligand (RANKL) gene expression was seen in association with an increase in osteoprotegerin gene expression ( fig 2A ).
← all excerpts
Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study.
1
—
—